Mariner Investment Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mariner Investment Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-169,700	Closed	-$2.81M	–	186
2016 Q1	$2.81M	Buy	169,700 +70,000	+70%	+$1.22M	0.78%	45
2015 Q4	$2.16M	Buy	+99,700	New	+$1.94M	0.48%	73
2015 Q3	–	Sell	-10,640	Closed	-$370K	–	250
2015 Q2	$370K	Sell	10,640 -43,182	-80%	-$1.32M	0.09%	147
2015 Q1	$1.4M	Sell	53,822 -10,000	-16%	-$183K	0.38%	83
2014 Q4	$823K	Buy	63,822 +43,822	+219%	+$549K	0.14%	133
2014 Q3	$246K	Buy	+20,000	New	+$232K	0.05%	166

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Mariner Investment Group's HZNP Position: Q2 2016 in Review

Mariner Investment Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 169,700 shares — an estimated $2.81M sold.

Mariner Investment Group first reported a position in HZNP in Q3 2014 and held it in 6 quarters. The position peaked at $2.81M in Q1 2016. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

Mariner Investment Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Mariner Investment Group sold 169,700 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $2.81M.
Mariner Investment Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 6 quarters.
Mariner Investment Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.81M in Q1 2016.
198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.